FDA Mammo Definition Key To New Breast Cancer Screening Benefits – CMS
This article was originally published in The Gray Sheet
Executive Summary
Eventual coverage of breast cancer screening technologies beyond mammography is contingent on revisions to FDA regulatory language, CMS Chief Medical Officer Sean Tunis warned June 14
You may also be interested in...
CMS Coverage Authority For Screening Tests Endorsed By Graham/Durbin
A bill introduced June 16 in the Senate would give the Centers for Medicare & Medicaid Services more discretion in covering screening tests
IoM Breast Cancer Detection Report Promotes Mammography Adjunct Tools
Widespread adoption of digital mammography for breast cancer detection will hinge on results from the National Cancer Institute's large trial comparing the technology with film screening, according to lead investigator Etta Pisano, MD, University of North Carolina at Chapel Hill
PET Cancer Coverage Decision Saves Dense-Breast Indication For Another Day
The Centers for Medicare & Medicaid Services is inviting interested parties to submit a separate coverage request for FDG-PET in women who have dense breast tissue